Sanne de Jongh - Gilde Healthcare


All team members
Sanne de Jongh
Investment Manager Therapeutics
The Netherlands

Sanne de Jongh

Investment Manager - Therapeutics

Sanne de Jongh joined Gilde Healthcare in 2017 and focuses on the biopharmaceutical sector. She is involved in deal sourcing, assessment of investment cases and portfolio management. She represents Gilde on the board of Calypso Biotech B.V. and ADCendo ApS.

Prior to joining Gilde, Sanne was with Anterra Capital for three years, a global food and ag tech fund backed by Fidelity and Rabobank. Here she worked on several biotech investments, such as Caribou Biosciences (IPO on Nasdaq: CRBU), Enko Chem and Agrimetis.

She began her career at MS Ventures, the biopharma fund of Merck KGaA, where she reviewed early stage strategic investments and supported the portfolio companies.

Sanne earned a masters degree (cum laude) in Biochemistry from Delft University of Technology, with a specialization in Neurology at the LUMC, the Netherlands. She is a Dutch citizen based in Gilde’s Utrecht office.

Pieter van der Meer

Managing Partner
Pieter van der Meer is founder and managing partner of Gilde Healthcare. Pieter joined Gilde in 1998 following a consultant position with KPMG Management Consulting. He is co-responsible for general management, the investment committees and...

Professor Dr. Rene Bernards

Operational Partner
Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute...

Michael R. Jaff, DO

Operational Partner
Michael R. Jaff, DO is the Chief Medical Officer and Vice-President of clinical affairs, technology and innovation at Boston Scientific Corporation. A professor of medicine at Harvard Medical School, Dr. Jaff was the President of...